Retatrutide 30mg Dual Chamber Pen

R3 (Retatrutide) – 30mg Dual Chamber Pen A next-generation metabolic research compound, R3 (Retatrutide) is presented in a precision-engineered 30mg dual chamber injection pen, designed for accuracy, stability, and ease of use. This advanced delivery system separates the lyophilized compound and diluent until activation, helping maintain compound integrity prior to mixing. With a simple twist-to-mix mechanism, the pen allows for a controlled reconstitution process, followed by precise, dial-based administration. Key Features * 30mg total content in a single integrated pen * Dual chamber system for enhanced stability * Twist-to-mix activation (A → B → C) * Pre-calibrated dosing mechanism for consistent delivery * Subcutaneous delivery format * Compact, travel-ready design Design Advantages * Maintains separation of powder and liquid until use * Minimizes handling compared to traditional vial reconstitution * Streamlined user experience with all-in-one format * Clear viewing chamber to monitor mixing and solution clarity Intended Use Developed for research and educational purposes, this compound is commonly studied for its role in metabolic regulation pathways, including multi-receptor activity associated with GLP-1, GIP, and glucagon signaling. Important * For research purposes only * Not for human consumption * Always follow proper handling, storage, and laboratory protocols